Nuo Therapeutics, Inc announced a Securities Purchase Agreement of 867,833 shares of the Company?s common stock, par value $0.0001 per share at a price of $0.75 per share for gross proceeds of $650,875 on May 10, 2024. The transaction includes participation of Scott M. Pittman, a member of the Board of Directors of the Company, Peter A. Clausen, the Chief Scientific and Chief Operating Officer of the Company, and Charles E. Sheedy, a principal stockholder of the Company of the Company. Messrs.

Pittman, Clausen, and Sheedy invested $101,250, $11,250, and $75,000, respectively, in the Private Placement. The shares of Common Stock were offered and sold pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506 of Regulation D promulgated thereunder, the Company desires to offer, issue and sell to the Purchasers and the Purchasers desire to purchase from the Company, up to 2,000,000 shares of the Company?s Common Stock, par value $0.0001 per share. The Company shall use its reasonable best efforts to hold the closing of the Offering no later May 17, 2024.

The transaction included participation from 11 investors pursuant to Regulation D.